Brief: Microba Life Sciences Says Q4 FY23 Unaudited Revenue Totalled A$2.25M
27/07/2023 02:31
July 27 (Reuters) - Microba Life Sciences Ltd MAP.AX :
* Q4 FY23 UNAUDITED REVENUE TOTALLED A$2.25M, UP 21.5% YOY
Source text for Eikon: ID:nASX76Lgjq
Further company coverage: MAP.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Microba Life Sciences
See all newsAustralia's Microba Life Sciences slumps to record low on discounted placement
Brief: Microba Life Sciences Secures A$5 Million Placement At A$0.05 Per Share
Brief: Microba Life Sciences Seeks Trading Halt
Brief: Microba Life Sciences Logs Qtrly Total Revenue A$3.36 Mln
Brief: Microba Life Sciences Posts HY Loss Attributable A$10.6 Million